Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents

NCT01691014 · clinicaltrials.gov ↗
TERMINATED
Status
79
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated on 10DEC2014 due to the inability to enroll the planned number of patients. There were no safety concerns.

Conditions

Interventions

Sponsor

Pfizer